AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
IDEXX Laboratories Executive Vice President Erickson Sells Shares on August 12, 2025.
ByAinvest
Thursday, Aug 14, 2025 6:59 pm ET1min read
IDEXX Laboratories Inc. / DE [IDXX] has disclosed that Erickson Michael G, Executive Vice President, has engaged in a transaction involving the sale of 318 shares at a price of $649.99 per share on August 12, 2025. Furthermore, he has also sold 87.89 shares at a price of $649.85 per share on the same date.
IDEXX Laboratories Inc. (NASDAQ:IDXX) has disclosed that Executive Vice President Michael G. Erickson has engaged in a transaction involving the sale of 318 shares at a price of $649.99 per share on August 12, 2025. Additionally, he has sold 87.89 shares at a price of $649.85 per share on the same date. These transactions were reported in the company's SEC Form 4 filing [1].Following these sales, Erickson directly owns 11,286 shares of IDEXX Laboratories. The total sale amount was $263,233, with a weighted average price of $649.8507. This sale comes amidst a period of strong financial performance and analyst upgrades for the company.
IDEXX Laboratories reported earnings of $3.63 per share (EPS) for the second quarter of 2025, beating analyst estimates of $3.28 by $0.35. The company also saw a 10.6% increase in revenue to $1.11 billion compared to the same period last year. This performance has led to a series of analyst upgrades, with price targets now ranging from $600 to $785, indicating strong market confidence and a consensus rating of "Moderate Buy" [2].
Institutional investors have also shown interest in IDEXX Laboratories. Vanguard Group Inc., for instance, increased its position in the company by 1.5% during the first quarter of 2025, owning 9,855,937 shares valued at $4,139,010,000 [3].
These transactions by Erickson and the positive market sentiment surrounding IDEXX Laboratories suggest a favorable outlook for the company's stock. However, investors should continue to monitor the company's performance and the broader market trends.
References:
[1] https://www.tradingview.com/news/tradingview:dd05ad172d888:0-idexx-laboratories-executive-sells-shares/
[2] https://www.tradingview.com/news/tradingview:c846fd65206a0:0-idexx-laboratories-executives-sell-over-23-million-in-company-stock/
[3] https://www.marketbeat.com/instant-alerts/insider-selling-idexx-laboratories-inc-nasdaqidxx-evp-sells-5450-shares-of-stock-2025-08-12/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet